Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Genomic landscape in small intestine cancer from real-world data (RWD) of clinical genomic testing.
Authors
Hiroyuki Takeda
Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Japan
Hiroyuki Takeda , Hiroyuki Yamamoto , Ritsuko Oikawa , Kumiko Umemoto , Ayako Doi , Yoshiki Horie , Takuro Mizukami , Takashi Ogura , Naoki Izawa , Jay A. Moore , Ethan Sokol , Yu Sunakawa
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Translational Research
DOI
10.1200/JCO.2022.40.4_suppl.642
Abstract #
642
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Genomic characterization of unresectable/recurrent early-onset gastric cancer by comprehensive genomic profiling tests.
First Author: Kunihito Matsuguma
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Comprehensive genomic profiling of advanced anal adenocarcinoma.
First Author: Nozomu Ogura
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Genomic classification of clinically advanced pancreatic ductal adenocarcinoma (PDAC) based on methylthioadenosine phosphorylase (MTAP) genomic loss (MTAP loss).
First Author: Natalie Ngoi
Poster
2021 ASCO Annual Meeting
Genomic alterations for novel targeted therapies in pancreatobiliary cancers from real-world data.
First Author: Kumiko Umemoto